Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A115K3 / Name: Summit / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Summit Therapeutics plc Stock

Pros and Cons of Summit Therapeutics plc in the next few years

Pros
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Summit Therapeutics plc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Summit Therapeutics plc - - - - - - -
Proteome Sciences -3.640% -1.852% 1.923% -26.389% -8.621% -3.636% 20.455%
Oxford BioMedica PLC 3.470% 1.456% 16.111% 3.980% -18.039% -24.685% -57.416%
Sareum Holdings plc - -5.348% 19.595% -55.528% -41.391% -92.371% -

News

This Healthcare Stock's Revolutionary Drug Could Make Early Investors Rich: https://g.foolcdn.com/editorial/images/824356/cancer-patient-flexing-muscle.jpg
This Healthcare Stock's Revolutionary Drug Could Make Early Investors Rich

Three years ago, Summit Therapeutics (NASDAQ: SMMT) was a little-known small-cap biotech that few investors with an average tolerance for risk would have bothered to pay attention to at the time

2 Soaring Stocks With More Upside Potential to Buy and Hold: https://g.foolcdn.com/editorial/images/823053/physician-giving-medicine-to-elderly-patient.jpg
2 Soaring Stocks With More Upside Potential to Buy and Hold

Is it worth it to buy a stock after it experiences significant market gains? The answer is, it depends. Some companies don't have much growth fuel left in the tank after a nice run, while others

Why Summit Therapeutics Stock Soared 8% Higher Today: https://g.foolcdn.com/editorial/images/823898/person-checking-medicine-on-a-shelf-in-a-pharmacy.jpg
Why Summit Therapeutics Stock Soared 8% Higher Today

One day before the July Fourth holiday, the stock of clinical-stage biotech Summit Therapeutics (NASDAQ: SMMT) exploded like a powerful fireworks display. Shares of the cancer-focused company leaped